Login / Signup

Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis.

Alexander KonnopkaHannah König
Published in: PharmacoEconomics (2020)
Using methods that focused on relative rather than absolute costs, we were able to aggregate costs reported in different COI studies for ADs. We found that ADs were associated with a low proportion of health care costs on a population level, but significantly increased health care costs on an individual level compared with healthy controls. Our disorder-specific subgroup analysis showed that study findings are most homogeneous within specific ADs. Therefore, to get a more detailed picture of the costs of ADs, more studies for currently under researched ADs, such as panic disorder, are needed.
Keyphrases
  • healthcare